← Back to Search

Combination Interventions for Anemia

Q: Is access to this experimental treatment available at the moment?

<p>Per the information available on clinicaltrials.gov, this particular research project has concluded recruitment and is no longer seeking participants. The study was initially posted on March 1st 2023 and last modified on February 16th 2023; however, there are currently 222 other trials that require volunteers.</p>

N/A

Waitlist Available

Led By Eric Thomas, MD,MPH

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

new, significant abnormal anemia (Hgb >1g/dl below normal, with normal white cells and platelets) or decreased estimated glomerular filtration rate (eGFR) (<60 ml/min/1.73m2 ) seen in one of the University of Texas Physicians (UTP) adult primary care clinics.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2.5 years

Awards & highlights

Study Summary

This trial assesses how EBIs affect patient safety & efficiency, & identifies any barriers that could affect their implementation.

Who is the study for?

This trial is for adults with new, significant anemia or reduced kidney function (eGFR <60 ml/min/1.73m2) seen at University of Texas Physicians clinics. It's not suitable for those who don't meet these specific blood and kidney health criteria.Check my eligibility

What is being tested?

The study tests whether usual care combined with specialist consultations improves patient safety and efficiency in diagnosing primary care conditions like anemia and reduced kidney function.See study design

What are the potential side effects?

Since the interventions involve usual medical care and additional specialist advice, side effects are not a primary concern of this trial but will depend on individual treatments received as part of standard care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2.5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2.5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of subjects who have correct diagnosis of cause of low glomerular filtration

Percentage of subjects who have correct diagnosis of cause of low hemoglobin

Secondary outcome measures

Cost of treatment

Fidelity as assessed by the percentage of participants who moved through each step of the diagnostic process needed for their diagnosis

Number of PCPs who find the intervention appropriate as assessed by survey of PCPs

+8 more

Trial Design

4Treatment groups

Experimental Treatment

Group I: Step 4 (4 clinics) - 24 months control followed by 6 months of interventionExperimental Treatment2 Interventions

Group II: Step 3 (3 clinics) - 18 months control followed by 12 months of interventionExperimental Treatment2 Interventions

Group III: Step 2 (3 clinics) - 12 months control followed by 18 months of interventionExperimental Treatment2 Interventions

Group IV: Step 1 (3 clinics) - 6 months control followed by 24 months of interventionExperimental Treatment2 Interventions

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

903 Previous Clinical Trials

319,609 Total Patients Enrolled

3 Trials studying Anemia

1,038 Patients Enrolled for Anemia

Eric Thomas, MD,MPHPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

Evidence-Based Interventions Clinical Trial Eligibility Overview. Trial Name: NCT05735314 — N/A

Anemia Research Study Groups: Step 1 (3 clinics) - 6 months control followed by 24 months of intervention, Step 2 (3 clinics) - 12 months control followed by 18 months of intervention, Step 3 (3 clinics) - 18 months control followed by 12 months of intervention, Step 4 (4 clinics) - 24 months control followed by 6 months of intervention

Anemia Clinical Trial 2023: Evidence-Based Interventions Highlights & Side Effects. Trial Name: NCT05735314 — N/A

Evidence-Based Interventions 2023 Treatment Timeline for Medical Study. Trial Name: NCT05735314 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is access to this experimental treatment available at the moment?

"Per the information available on clinicaltrials.gov, this particular research project has concluded recruitment and is no longer seeking participants. The study was initially posted on March 1st 2023 and last modified on February 16th 2023; however, there are currently 222 other trials that require volunteers."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

Eric Thomas 2023. "A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05735314.

All > Anemia